Efficacy of Trametinib in Neurofibromatosis Type 1–Associated Gastrointestinal Stromal Tumors: A Case Report

Authors

Misao Fukuda

Published

August 1, 2024

Abstract

Trametinib, an MEK inhibitor, may offer a new therapeutic option for patients with NF1-related GIST.

Supporters

Support the authors with ResearchCoin

Journal

JCO Precision Oncology

Topics

DOI

10.1200/po.23.00649

Efficacy of Trametinib in Neurofibromatosis Type 1–Associated Gastrointestinal Stromal Tumors: A Case Report

Authors

Misao Fukuda

Published

August 1, 2024

Abstract

Trametinib, an MEK inhibitor, may offer a new therapeutic option for patients with NF1-related GIST.

Supporters

Support the authors with ResearchCoin

Journal

JCO Precision Oncology

Topics

DOI

10.1200/po.23.00649

Paper

Paper

Paper

Paper

Efficacy of Trametinib in Neurofibromatosis Type 1–Associated Gastrointestinal Stromal Tumors: A Case Report

Abstract

Supporters

Journal

Topics

DOI

Efficacy of Trametinib in Neurofibromatosis Type 1–Associated Gastrointestinal Stromal Tumors: A Case Report

Abstract

Supporters

Journal

Topics

DOI